Beam Therapeutics Inc
BEAM
Market Cap$1.69B
Close$
$-24.21
252.9% downside
Current Fair Value
252.9% downsideOvervalued by 252.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.69 Billion |
|---|---|
| Enterprise Value | $1.41 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.58 |
| Beta | 2.35 |
| Outstanding Shares | 87,975,311 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.82 |
|---|---|
| PEG | -633.27 |
| Price to Sales | 5.28 |
| Price to Book Ratio | 1.32 |
| Enterprise Value to Revenue | 4.03 |
| Enterprise Value to EBIT | -7.48 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
ESG Score
No data